| Symbol |
Name |
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ANGPT2
|
angiopoietin 2
|
|
ANXA5
|
annexin A5
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
BRCA1
|
breast cancer 1, early onset
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
CANT1
|
calcium activated nucleotidase 1
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CD40LG
|
CD40 ligand
|
|
CFH
|
complement factor H
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CRH
|
corticotropin releasing hormone
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTSG
|
cathepsin G
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2
|
|
EDN1
|
endothelin 1
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ENG
|
endoglin
|
|
F10
|
coagulation factor X
|
|
F11
|
coagulation factor XI
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL2
|
coagulation factor II (thrombin) receptor-like 2
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FGA
|
fibrinogen alpha chain
|
|
FGB
|
fibrinogen beta chain
|
|
FGL2
|
fibrinogen-like 2
|
|
GGCX
|
gamma-glutamyl carboxylase
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GZMM
|
granzyme M (lymphocyte met-ase 1)
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HMGB1
|
high mobility group box 1
|
|
HPSE
|
heparanase
|
|
HRG
|
histidine-rich glycoprotein
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IL1B
|
interleukin 1, beta
|
|
IL32
|
interleukin 32
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAK2
|
Janus kinase 2
|
|
KLK1
|
kallikrein 1
|
|
LCN2
|
lipocalin 2
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LIMK1
|
LIM domain kinase 1
|
|
LMAN1
|
lectin, mannose-binding, 1
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)
|
|
MCFD2
|
multiple coagulation factor deficiency 2
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR122
|
microRNA 122
|
|
MMP10
|
matrix metallopeptidase 10
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
OSM
|
oncostatin M
|
|
P2RX1
|
purinergic receptor P2X, ligand gated ion channel, 1
|
|
PDIA2
|
protein disulfide isomerase family A, member 2
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLG
|
plasminogen
|
|
PLVAP
|
plasmalemma vesicle associated protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROS1
|
protein S (alpha)
|
|
PROZ
|
protein Z, vitamin K-dependent plasma glycoprotein
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTX3
|
pentraxin 3, long
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RPS19
|
ribosomal protein S19
|
|
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SSH1
|
slingshot protein phosphatase 1
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
TAC1
|
tachykinin, precursor 1
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TF
|
transferrin
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
THBD
|
thrombomodulin
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TNF
|
tumor necrosis factor
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
VCAN
|
versican
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VTN
|
vitronectin
|
|
VWF
|
von Willebrand factor
|
